Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 2.45% is 266% above its 5-year average of -1.48%, around the middle of its 5-year range (-14.11%–10.06%).
948.63% above its 12-month average of 0.23%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2.43%.
OPERATING MARGIN
2.45%
OPERATING MARGIN AVG TTM
0.23%
OPERATING MARGIN AVG 3Y
-3.62%
OPERATING MARGIN AVG 5Y
-1.48%
OPERATING MARGIN AVG 10Y
0.52%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+948.63%
CURRENT VS 3Y AVG
+167.75%
CURRENT VS 5Y AVG
+265.96%
CURRENT VS 10Y AVG
+374.75%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
The Joint Corp.
Market Cap
$102.71M
Operating Margin
2.45%
TTM Avg
0.23%
3Y Avg
-3.62%
5Y Avg
-1.48%
Market Cap
$103.43M
Operating Margin
28.39%
TTM Avg
14.20%
3Y Avg
7.10%
5Y Avg
4.73%
Market Cap
$103.67M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$103.70M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$104.45M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1310.83%
5Y Avg
-1301.48%
Market Cap
$104.90M
Operating Margin
-8.52%
TTM Avg
-145.19%
3Y Avg
-110.33%
5Y Avg
-78.53%
Market Cap
$106.50M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$106.75M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1578.22%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Joint Corp. (JYNT) | $102.71M | 2.45% | 0.23% | -3.62% | -1.48% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.43M | 28.39% | 14.20% | 7.10% | 4.73% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $103.67M | 0.00% | 0.00% | 0.00% | 0.00% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $103.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.45M | 0.00% | 0.00% | -1310.83% | -1301.48% |
| Definitive Healthcare Corp. (DH)vs › | $104.90M | -8.52% | -145.19% | -110.33% | -78.53% |
| PolyPid Ltd. (PYPD)vs › | $99.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Vivani Medical, Inc. (VANI)vs › | $106.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.75M | 0.00% | 0.00% | 0.00% | -1578.22% |
| Immunic, Inc. (IMUX)vs › | $107.06M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
81.1%
Operating Margin
2.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -2.43% |
| 2026-03-31 | 6.07% |
| 2025-12-31 | 4.90% |
| 2025-09-30 | 1.20% |
| 2025-06-30 | -8.58% |
| 2025-03-31 | -5.19% |
| 2024-12-31 | -10.03% |
| 2024-09-30 | -10.55% |
| 2024-06-30 | -14.11% |
| 2024-03-31 | -3.50% |
| 2023-12-31 | -0.48% |
| 2023-09-30 | -3.05% |
| 2023-06-30 | -1.28% |
| 2023-03-31 | -2.31% |
| 2022-12-31 | 4.60% |
| 2022-09-30 | 2.77% |
| 2022-06-30 | -5.35% |
| 2022-03-31 | -0.17% |
| 2021-12-31 | 0.03% |
| 2021-09-30 | 6.38% |
| 2021-06-30 | 10.06% |
| 2021-03-31 | 11.24% |
| 2020-12-31 | 16.29% |
| 2020-09-30 | 11.07% |
| 2020-06-30 | 2.05% |
| 2020-03-31 | 5.52% |
| 2019-12-31 | 9.68% |
| 2019-09-30 | 5.03% |
| 2019-06-30 | 4.37% |
| 2019-03-31 | 9.82% |
| 2018-12-31 | 10.32% |
| 2018-09-30 | -2.37% |
| 2018-06-30 | -1.33% |
| 2018-03-31 | -6.19% |
| 2017-12-31 | -3.26% |
| 2017-09-30 | -5.77% |
| 2017-06-30 | -16.37% |
| 2017-03-31 | -27.97% |
| 2016-12-31 | -99.15% |
| 2016-09-30 | -47.51% |
| 2016-06-30 | -64.15% |
| 2016-03-31 | -81.73% |
| 2015-12-31 | -93.13% |
| 2015-09-30 | -49.56% |
| 2015-06-30 | -53.87% |
| 2015-03-31 | -76.37% |
| 2014-12-31 | -45.56% |
| 2014-09-30 | -17.11% |
| 2014-06-30 | -12.08% |
| 2014-03-31 | -10.40% |
| 2013-12-31 | 8.55% |
| 2013-09-30 | 13.15% |
